Craig Hofmeister (@eaglemyeloma) 's Twitter Profile
Craig Hofmeister

@eaglemyeloma

Clinical investigator at Emory focused on myeloma & amyloidosis, dreaming of curing cancer while improving quality.

ID: 2234845399

linkhttps://winshipcancer.emory.edu/craig-hofmeister calendar_today07-12-2013 17:42:56

2,2K Tweet

3,3K Followers

332 Following

Noopur Raje (@noopurrajemd) 's Twitter Profile Photo

Truly a sad day for all of us in the myeloma world.. Jack was a force in our fight against #mmsm.. RIP Jack! We miss you and love you!

Timothy Schmidt, MD (@tmschmidtmd) 's Twitter Profile Photo

Perhaps the best figure I've found supporting the use of Dara+Len maintenance after ASCT among those receiving DaraVRd. Even among MRD- patients, PFS looks better for DR vs R. Still not sure it's worth adding for everyone, but I'm more supportive of it. rdcu.be/dPFo2

Perhaps the best figure I've found supporting the use of Dara+Len maintenance after ASCT among those receiving DaraVRd. Even among MRD- patients, PFS looks better for DR vs R.

Still not sure it's worth adding for everyone, but I'm more supportive of it.

rdcu.be/dPFo2
Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

15.6m US adults reported at least one potentially liver toxic botanical supplement w/in 30 days - turmeric was most frequently reported, followed in order by green tea, ashwagandha, Garcinia cambogia, red yeast rice, and black cohosh products. ☹️ jamanetwork.com/journals/jaman…

Rahul Banerjee, MD, FACP (@rahulbanerjeemd) 's Twitter Profile Photo

I’d prescribe SGLT2 inhibitors over chronic doxycycline in a heartbeat for patients with AL amyloidosis with cardiac involvement… Great work by Lang Raj Chakraborty Suzanne Lentzsch, MD, PhD et al! Hopefully positive prospective studies with this to come 🤞🏼

Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽 (@rfonsi1) 's Twitter Profile Photo

Clearly defines risk of CRS and ICANs in the first two weeks. No need to have patients stick around for a month closer to treatment centers and impose driving restrictions - for what? Thanks you Dr Nausheen Ahmed MD Saurabh Chhabra #mmsm

Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

If the U.S. government wants to get serious about encouraging people to eat beans, it should offer workshops and online videos on delicious, easy ways to cook them nytimes.com/2024/08/12/opi…

Elisabeth Rosenthal (@rosenthalhealth) 's Twitter Profile Photo

What’s going on? Observation: the ER is now 4 or 5 times the size than when I worked there. But the number of true inpatient beds hasn’t increased proportionately. Hospitals can charge you for an inpatient room in the overflow unit. 5/9

Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

Did you know that the prescribing insert with Elranatamab includes pulmonary embolism but this did not occur with Teclistamab? #mmsm

Aaron Goodman - “Papa Heme” (@aarongoodman33) 's Twitter Profile Photo

MGUS + "x" = MGCS! + neuropathy+VEGF = POEMS + neutrophilic urticaria = Schnitzler + cutaneous mucinosis = Scleromyxedema + ataxic neuropathy+opthalmoplegia= CANOMAD + angioedema = C1 inhibitor deficiency + bleeding = aVWD + erythrocytosis+pulm shunting+telangiectasias = TEMPI

MGUS + "x"  = MGCS!

+ neuropathy+VEGF = POEMS
+ neutrophilic urticaria = Schnitzler
+ cutaneous mucinosis = Scleromyxedema
+ ataxic neuropathy+opthalmoplegia= CANOMAD
+ angioedema = C1 inhibitor deficiency
+ bleeding = aVWD
+ erythrocytosis+pulm shunting+telangiectasias = TEMPI
Hamza Hashmi (@hhashmi87) 's Twitter Profile Photo

Hot off Press: Safety and Efficacy of #CART in #RRMM w sec #AL #Amyloidosis led by resident Cleveland Clinic ➡️Responses were rapid and deep ➡️No excessive or ⬆️Gr CRS ➡️Presence of amyloid should not be🛑🚧 CART pubmed.ncbi.nlm.nih.gov/39189919/ #mmsm #MedTwitter #UnmetNeed eJHaem Journal

Hot off Press: Safety and Efficacy of #CART in #RRMM w sec #AL #Amyloidosis led by resident <a href="/ClevelandClinic/">Cleveland Clinic</a> 
➡️Responses were rapid and deep
➡️No excessive or ⬆️Gr CRS
➡️Presence of amyloid should not be🛑🚧 CART
pubmed.ncbi.nlm.nih.gov/39189919/
#mmsm #MedTwitter #UnmetNeed <a href="/e_JHaem/">eJHaem Journal</a>
Jim Omel (@imfjimmyeloma) 's Twitter Profile Photo

Rep. John Garamendi announces he has multiple myeloma, will continue working through treatment msn.com/en-us/health/o… With a good myeloma specialist helping you pick the right trtmt plan, normal life can go on despite having myeloma.

Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

In addition to steroids & 5HT3i, olanzapine should be considered as one of the standards of care to reduce chemotherapy-induced nausea and vomiting among patients receiving moderately emtogenic chemotherapy. #mmsm ncbi.nlm.nih.gov/pmc/articles/P…

Dr. John Cush (@rheumnow) 's Twitter Profile Photo

It takes >3-4 weeks of steroids (@ any dose >5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of <3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6

It takes &gt;3-4 weeks of steroids (@ any dose &gt;5 mg pred/d) to pose risk of adrenal insufficiency – Hence, Endocrine Society Guideline says short-term glucocorticoid therapy of &lt;3-4 wks, irrespective of dose, DOES NOT require GC tapering buff.ly/4gggMq6
Andrew Yee, MD (@andrew02114) 's Twitter Profile Photo

Mass spectrometry is one of the most sensitive ways for detecting monoclonal protein in the peripheral blood. Similar to how there are different ways of detecting MRD in bone marrow (next generation sequencing or flow cytometry), there are different types of mass spec platforms

Mass spectrometry is one of the most sensitive ways for detecting monoclonal protein in the peripheral blood.  Similar to how there are different ways of detecting MRD in bone marrow (next generation sequencing or flow cytometry), there are different types of mass spec platforms
Jim Omel (@imfjimmyeloma) 's Twitter Profile Photo

Lower-Intensity Talquetamab Dose Shows Potential in Multiple Myeloma targetedonc.com/view/lower-int… via @targetedonc Lower dose equates with lower toxicity and less T-cell exhaustion. Efficacy was maintained. We don't always need MTD. Let's please go for MED (minimal effective dose).

Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

Denosumab $24,528 isn't worth it in patients with good renal function. Need our guidelines to go with the data (Larocca, Blood, 2013, PMID 23974194) and not Novartis marketing (PMID 22498739) - no bisphosphonate at all if #myeloma is in control. #mmsm pubmed.ncbi.nlm.nih.gov/39207867/

Craig Hofmeister (@eaglemyeloma) 's Twitter Profile Photo

Does the serum free light chain assay matter? Here's a good comparison of Freelite vs Sebia showing equivalence; I bet we won't see this with Diazyme. #mmsm pubmed.ncbi.nlm.nih.gov/39206639/